182 related articles for article (PubMed ID: 15519184)
1. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response.
van den Goor J; Nieuwland R; van den Brink A; van Oeveren W; Rutten P; Tijssen J; Eijsman L
Eur J Cardiothorac Surg; 2004 Nov; 26(5):926-31. PubMed ID: 15519184
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
Hoel TN; Videm V; Baksaas ST; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
[TBL] [Abstract][Full Text] [Related]
4. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
[TBL] [Abstract][Full Text] [Related]
6. Active or passive bio-coating: does it matters in extracorporeal circulation?
Jacobs S; De Somer F; Vandenplas G; Van Belleghem Y; Taeymans Y; Van Nooten G
Perfusion; 2011 Nov; 26(6):496-502. PubMed ID: 21719530
[TBL] [Abstract][Full Text] [Related]
7. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
[TBL] [Abstract][Full Text] [Related]
8. Effect of Carmeda BioActive Surface coating versus Trillium Biopassive Surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass.
Palanzo DA; Zarro DL; Manley NJ; Montesano RM; Quinn M; Elmore BA; Gustafson PA; Castagna JM
Perfusion; 2001 Jul; 16(4):279-83. PubMed ID: 11486846
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
[TBL] [Abstract][Full Text] [Related]
10. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
Sohn N; Marcoux J; Mycyk T; Krahn J; Meng Q
Perfusion; 2009 Jul; 24(4):231-7. PubMed ID: 19858237
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
[TBL] [Abstract][Full Text] [Related]
12. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
[TBL] [Abstract][Full Text] [Related]
13. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
[TBL] [Abstract][Full Text] [Related]
14. Trillium-coated oxygenators in adult open-heart surgery: a prospective randomized trial.
Dickinson T; Mahoney CB; Simmons M; Marison A; Polanski P
J Extra Corpor Technol; 2002 Dec; 34(4):248-53. PubMed ID: 12533060
[TBL] [Abstract][Full Text] [Related]
15. Secretory phospholipase A(2) activity and release kinetics of vascular tissue remodelling biomarkers after coronary artery bypass grafting with and without cardiopulmonary bypass.
Varnous S; Ben Ayed S; Masliah J; Leprince P; Gandjbakhch I; Bernard M; Beaudeux JL
Clin Chem Lab Med; 2007; 45(3):372-5. PubMed ID: 17378735
[TBL] [Abstract][Full Text] [Related]
16. PMEA coating of pump circuit and oxygenator may attenuate the early systemic inflammatory response in cardiopulmonary bypass surgery.
Ueyama K; Nishimura K; Nishina T; Nakamura T; Ikeda T; Komeda M
ASAIO J; 2004; 50(4):369-72. PubMed ID: 15307550
[TBL] [Abstract][Full Text] [Related]
17. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia.
Bruins P; te Velthuis H; Yazdanbakhsh AP; Jansen PG; van Hardevelt FW; de Beaumont EM; Wildevuur CR; Eijsman L; Trouwborst A; Hack CE
Circulation; 1997 Nov; 96(10):3542-8. PubMed ID: 9396453
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation.
Fransen E; Maessen J; Dentener M; Senden N; Geskes G; Buurman W
Chest; 1998 May; 113(5):1290-5. PubMed ID: 9596308
[TBL] [Abstract][Full Text] [Related]
19. Pulsatile compared with nonpulsatile perfusion using a centrifugal pump for cardiopulmonary bypass during coronary artery bypass grafting. Effects on systemic haemodynamics, oxygenation, and inflammatory response parameters.
Driessen JJ; Dhaese H; Fransen G; Verrelst P; Rondelez L; Gevaert L; van Becelaere M; Schelstraete E
Perfusion; 1995; 10(1):3-12. PubMed ID: 7795311
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass.
De SF; Van BY; Caes F; François K; Arnout J; Bossuyt X; Taeymans Y; Van NG
Perfusion; 2002 Jan; 17(1):39-44. PubMed ID: 11817528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
